Treatment of paroxysmal nocturnal hemoglobinuria in pregnancy with eculizumab: A case report
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare disease caused by mutations in hematopoietic stem cells leading to pancytopenia and a predisposition for thromboembolic events. In pregnancy, these manifestations can be amplified, leading to increased neonatal and maternal morbidity and mortality....
Main Authors: | Michael J. Fassett, Adrian L. Hernandez Lopez |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-04-01
|
Series: | Case Reports in Women's Health |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214911221000126 |
Similar Items
-
Eculizumab in the management of paroxysmal nocturnal hemoglobinuria: patient selection and special considerations
by: Al-Ani F, et al.
Published: (2016-08-01) -
Efficacy and safety of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (PNH) after 15 years steroids treatment: a case report description
by: Endri Mauro, Filippo Gherlinzoni
Published: (2019-11-01) -
Pregnancy in Classical Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia–Paroxysmal Nocturnal Hemoglobinuria: A High-Risk Constellation
by: Ferras Alashkar, et al.
Published: (2020-09-01) -
Treatment of paroxysmal nocturnal hemoglobinuria
by: I. A. Lisukov, et al.
Published: (2014-07-01) -
Treatment of paroxysmal nocturnal hemoglobinuria
by: I. A. Lisukov, et al.
Published: (2014-07-01)